Guidelines for Experiments using Antisense Oligonucleotides and Double-Stranded RNAs

Presenter: David Corey PhD, University of Texas, USA Date: 6 December 2018 Description: After decades of research and development, synthetic nucleic acids are beginning to enjoy significant success in the clinic. Approved drugs have increased interest in the field and many basic research studies have focused on synthetic nucleic acids that are intended to control…

Sleepless in Seattle

The 14th annual meeting of the Oligonucleotide Therapeutics Society took place at the Marriott Seattle Waterfront hotel in Seattle, USA, from the 30th of September to the 3rd of October. With nearly 600 attendees and 150 posters it was the biggest OTS meeting yet. Perhaps it was the Society’s increased social media engagement and educational…